Azelaic acid clinical trials
Also written Finacea.
How each study uses azelaic acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the azelaic acid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 13 Sept 1995 · AZELEX · NDA 020428 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
25 studies that test it; most in 2010 (5)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 5 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 13 · Other 12
LEO Pharma (6) · Galderma R&D (3) · Wake Forest University Health Sciences (2) · Taro Pharmaceuticals USA (2) · Derm Research, PLLC (2) · University of Guadalajara (1) · Gujranwala medical college District Headquarters Hospital, Gujranwala (1) · Dermatology Specialists Research (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test azelaic acid.
- Nov 2026Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)Early Phase 1 · Wake Forest University Health Sciences
- Nov 2027Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing RadiationPhase 1 · Virginia Commonwealth University
Studies
Open first, then newest update. How each study uses azelaic acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 25
- Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing RadiationRecruitingPhase 1Virginia Commonwealth UniversityNCT06966388Written as Azelaic AcidHow we know
- Efficacy and Safety of a Combined Topical Formula Versus Placebo in Patients With MelasmaCompletedNot applicableUniversity of GuadalajaraNCT07727954Written as Topical azelaic acid 12% plus tranexamic acid 5%How we know
- Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)Active, not recruitingEarly Phase 1Wake Forest University Health SciencesNCT05416333Written as azelaic acidHow we know
- Azelaic Acid 20% vs Hydroquinone 4% in Epidermal MelasmaCompletedNot applicableGujranwala medical college District Headquarters Hospital, GujranwalaNCT07327983Written as Topical Azelaic Acid 20% CreamHow we know
- To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical GelCompletedPhase 1Taro Pharmaceuticals USANCT03094403Written as Azelaic Acid 15% topical gelHow we know
- A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the FaceCompletedPhase 2LEO PharmaNCT00408330Written as Azelaic Acid 15% GelHow we know
- Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate AcneCompletedPhase 3LEO PharmaNCT00031096Written as Azelaic Acid Gel 15% (Finacea, BAY39-6251)How we know
- A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral DermatitisCompletedPhase 2LEO PharmaNCT00403949Written as Azelaic acid 15% gelHow we know
- A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once DailyCompletedPhase 4LEO PharmaNCT00417937Written as azelaic acid 15% gelHow we know
- Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of RosaceaCompletedPhase 3Galderma R&DNCT01659853Written as azelaic acid gel 15%How we know
- Split-Face Tolerability Comparison Between MetroGel® 1% Versus Finacea® 15% in Subjects With Healthy SkinCompletedPhase 4Galderma R&DNCT01139008Written as azelaic acid 15% gelHow we know
- Split-face Tolerability Comparison Between MetroGel® 1% vs Finacea® 15% in Subjects With Healthy SkinCompletedPhase 4Galderma R&DNCT01139047Written as azelaic acid 15% gelHow we know
- Efficacy of Oral Minocycline (Solodyn) and Oral Minocycline (Solodyn) Plus Azelaic Acid (Finacea) for Acne RosaceaCompletedPhase 4Dermatology Specialists ResearchNCT05014906Written as Azelaic acidHow we know
- A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial RosaceaCompletedPhase 3Actavis Inc.NCT02120924Written as Azelaic acidHow we know
- Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in RosaceaCompletedPhase 2LEO PharmaNCT00617903Written as Azelaic acidHow we know
- Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular RosaceaCompletedPhase 4LEO PharmaNCT00855595Written as Azelaic acid (Finacea, BAY39-6251)How we know
- Azelaic Acid Foam 15% in the Treatment of Papulopustular RosaceaCompletedPhase 4Clinical Research Center of the CarolinasNCT03418610Written as Azelaic Acid foam 15%How we know
- To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial RosaceaCompletedPhase 1Taro Pharmaceuticals USANCT03689010Written as Finacea® (Azelaic acid Foam) 15%How we know
- Combination Gel and Vascular ND in Mild to Moderate RosaceaCompletedNot applicableWake Forest University Health SciencesNCT01631656Written as Azelaic acidHow we know
- Azelaic Acid on Demodex Counts in RosaceaCompletedPhase 2/3Wake Forest UniversityNCT03035955Written as Azelaic acidHow we know
See all 25 studies that test azelaic acid →
As the comparator · 2 — what is tested is compared with azelaic acid
- Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular RosaceaCompletedPhase 1LEO PharmaNCT01257919Written as Azelaic Acid GelHow we know
- A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With RosaceaCompletedPhase 3Actavis Inc.NCT03287791Written as Finacea® (Azelaic Acid) FoamHow we know
Codes
What other systems call azelaic acid · ClinicalTrials.gg INT002474
- MeSH (NLM) C010038azelaic acidConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) F2VW3D43YTAZELAIC ACIDConfirmed FDA, NLM, Wikidata
- RxNorm 18602Confirmed FDA, Wikidata
- Wikidata Q413504azelaic acidConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47407Azelaic AcidOne source FDA
- DrugBank DB00548One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C010038 | azelaic acid | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | F2VW3D43YT | AZELAIC ACID | Confirmed FDA, NLM, Wikidata |
| RxNorm | 18602 | — | Confirmed FDA, Wikidata |
| Wikidata | Q413504 | azelaic acid | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47407 | Azelaic Acid | One source FDA |
| DrugBank | DB00548 | — | One source Wikidata |
Also registered as dipotassium azelate (UNII C98170693J), disodium azelate (UNII 0P4H8NH3UJ · RxNorm 2117384) and monosodium azelate (UNII 5816841A8F).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.